Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > $50.00 target
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Marwoodon Jun 22, 2016 11:38pm
196 Views
Post# 24989830

RE:RE:$50.00 target

RE:RE:$50.00 targetHamSandwich, We need more rational (less speculative) posters like you. Thank you.
HamSandwich wrote:
20dollarsilver wrote: was told by a broker friend that this was an easy 50 dollar stock in next 6 months. with all the new revenue coming soon it seems reasonable to me. sure is cheap at this price.


your broker friend is either a charlatan, incompetent, or an idiot. 

An "easy" 67% return in 6 months?  Come on man.

If market timing was this easy he'd be a billionaire.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities